Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | YL202 |
Trade Name | |
Synonyms | YL 202|YL-202 |
Drug Descriptions |
YL202 is an antibody-drug conjugate (ADC) comprising an ERBB3 (HER3)-targeted antibody conjugated to a novel topoisomerase I inhibitor, which potentially inhibits tumor growth (Cancer Res (2023) 83 (7_Supplement): 563). |
DrugClasses | HER3 (ERBB3) Antibody 23 |
CAS Registry Number | NA |
NCIT ID | C199281 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
YL202 | YL202 | 0 | 1 |